Advances in prevention and management of central line-associated bloodstream infections in patients with cancer

Clin Infect Dis. 2014 Nov 15:59 Suppl 5:S340-3. doi: 10.1093/cid/ciu670.

Abstract

Central lines, which are essential for treating cancer, are associated with at least 400,000 episodes of bloodstream infection in patients with cancer every year in the United States. Effective novel interventions for preventing and managing these infections include antimicrobial-coated catheters and antimicrobial lock solutions.

Keywords: cancer patients; catheter-related infections; central line–associated bloodstream infections; central venous catheters; prevention and management.

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Bacteremia / drug therapy*
  • Bacteremia / etiology
  • Bacteremia / microbiology
  • Bacteremia / prevention & control*
  • Catheterization, Central Venous / adverse effects*
  • Humans
  • Neoplasms / complications*

Substances

  • Anti-Bacterial Agents